Celcuity Inc. 8-K Summary
Business Context and Reporting Period
Celcuity Inc. (CELC), a Delaware corporation headquartered in Minneapolis, Minnesota, filed this Current Report on Form 8-K on November 12, 2025. The filing serves to announce the Company's financial results for the third quarter ended September 30, 2025.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the text of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, management commentary, risk factors, or details on unusual items. It strictly notifies the market of the issuance of the Q3 2025 press release. The document includes a standard disclaimer stating that the information in Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2025) for actual Q3 2025 financial figures.
- Verify the Company's cash position and burn rate, as these are critical for pre-revenue or early-stage biotech firms.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.
- Confirm the trading status of CELC on The Nasdaq Stock Market LLC.